Home > Lab Tests > Canassist - Breast (L) Test

Canassist - Breast (L) Test

₹75,000/-

1 tests included

Home Sample Collection Available

ADD

No fasting required

15 Days

Both

All age group

Formalin fixed paraffin embedded tissue

View / Download Sample Report

Includes 1 TestsThis package includes following parameters

Quick Summary: The Canassist - Breast (L) Test for Both patients, all age group, with reports available 15 days — currently offered at ₹75,000 . Home Sample Collection is available

Canassist - Breast (L) Test

₹ 75000

ADD

Test Name :	Canassist - Breast (L) Test
Sample Type :	Formalin fixed paraffin embedded tissue
Gender :	Both
Age group :	All Age Groups
Test Components :	View

Price :	₹ 75000
Home Collection :	Available

Test Components View

Certified

Phlebotomist

🏥

Division of

Max Healthcare

🧪

Safe Sample

Collection

📊

Accurate &

Quality Reports

⏱️

Same Day

Report*

Trusted by Professionals

Overview of the Test
When is the Test Prescribed?
Time Required for Test Report + Next Step
Test Procedure
Understanding the Test Report
Next Steps After the Report
How to Book Canassist - Breast (L) at Home Near Me?
Frequently Asked Questions (FAQs) about Canassist - Breast (L)

Description
Canassist breast cancer test is a predictive diagnostic tool that helps determine the risk of recurrence in early-stage, hormone receptor-positive breast cancer. Using advanced technology, the Canassist breast test analyses tumour biology through protein expression. This procedure helps oncologists to decide whether chemotherapy is required or not. By distinguishing between low and high-risk patients, the Canassist breast test supports personalised treatment decisions, allowing many to avoid

Canassist breast cancer test is a predictive diagnostic tool that helps determine the risk of recurrence in early-stage, hormone receptor-positive breast cancer. Using advanced technology, the Canassist breast test analyses tumour biology through protein expression. This procedure helps oncologists to decide whether chemotherapy is required or not. By distinguishing between low and high-risk patients, the Canassist breast test supports personalised treatment decisions, allowing many to avoid unnecessary chemotherapy and its side effects.

Overview of the Test

Canassist Breast cancer primarily affects women, particularly those over the age of 40, although men can also develop the disease. The Canassist breast test is designed for patients diagnosed with early-stage, hormone receptor-positive, HER2-negative breast cancer, a type that is mostly treated with hormone therapy.

However, many of these patients are unnecessarily subjected to chemotherapy. The Canassist breast lab test addresses this by accurately identifying those who can be treated effectively without chemotherapy.

The test works by analysing five specific protein biomarkers related to cancer progression and metastasis. Based on the results, the Canassist breast test report categorises patients into:

Low-risk: this indicates chemotherapy may not be necessary
High-risk: suggests chemotherapy might be beneficial

This classification plays a vital role in treatment planning post-surgery, helping oncologists tailor treatment to individual patients.

When is the Test Prescribed?

Canassist breast cancer can develop due to a combination of genetic, hormonal, and lifestyle factors. The primary causes include age and gender, with women over the age of 40 being most commonly affected. A family history of breast cancer or known genetic mutations, such as BRCA1 and BRCA2, can significantly increase risk. Hormonal influences, particularly prolonged hormone replacement therapy, can also contribute. Additional factors like obesity, alcohol consumption, and environmental exposure are known to elevate the likelihood of developing Canassist breast cancer. Understanding these risks helps identify when a patient might benefit from the Canassist breast test.

Symptoms prompting consideration of the Canassist Breast lab test often include the presence of a new lump in the breast or underarm, noticeable changes in the shape, size, or appearance of the breast, or alterations in the nipple such as discharge, inversion, or unusual tenderness. Patients may also experience persistent breast pain or observe redness, dimpling, or irritation of the breast skin. While these signs do not always confirm cancer, they are indicators that warrant medical evaluation. If breast cancer is confirmed, the Canassist Breast test is a valuable next step to assess the likelihood of recurrence.

In terms of prevention, although not all types of Canassist Breast cancer can be entirely avoided, there are proactive steps individuals can take to lower their risk. These include attending regular screenings and mammograms, adopting a healthy diet, maintaining a proper weight, engaging in physical activity, and moderating alcohol consumption. It is also advisable to avoid tobacco use and carefully manage any hormone-based therapies.

The Canassist breast test is generally prescribed after the surgical removal of the tumour. At this stage, oncologists need to determine whether chemotherapy is essential. This is where the Canassist Breast test report becomes crucial, as it evaluates the risk of cancer recurrence based on tumour biology. By analysing key biomarkers, the Canassist breast test results support personalised treatment strategies. If the patient is deemed low-risk, they may be spared the physical and emotional burden of chemotherapy. Conversely, those categorised as high-risk can be given a more aggressive treatment plan to improve long-term outcomes. The Canassist breast test procedure provides clinicians with the data necessary to make confident, evidence-based decisions.

Time Required for Test Report + Next Step

At MAX Lab, the Canassist breast test procedure is streamlined to offer patients a seamless and efficient diagnostic experience.

Test Procedure

Sample Collection: The Canassist Breast test requires a formalin-fixed paraffin-embedded (FFPE) tumour tissue sample, usually obtained after a biopsy or surgery.
Lab Analysis: Forward the sample to a specialised laboratory where the expression of five crucial protein biomarkers is analysed using immunohistochemistry (IHC). The Canassist Breast lab test uses a proprietary algorithm to assign a risk category.
Test Duration: The Canassist Breast test report is generally available within 10 to 14 working days once the tissue sample is received at the lab.

Understanding the Test Report

The Canassist Breast test results provide a risk score and indicate whether the patient falls into the low- or high-risk category:

Low-risk: Likely to benefit from hormone therapy alone
High-risk: May require chemotherapy in addition to hormone therapy

The detailed Canassist breast test report includes:

Risk score
Biomarker details
Clinical interpretation
Treatment recommendations for oncologists

Next Steps After the Report

Once the Canassist breast test report is ready, MAX Lab coordinates a consultation with the oncology team. During this consultation, the oncologist:

Explains the risk score and its implications
Recommends treatment based on risk category
Discusses side effects, next steps, and long-term management

This multidisciplinary approach ensures every patient receives personalised, evidence-based care.

Frequently Asked Questions (FAQs) about Canassist - Breast (L)

The CanAssist test for breast cancer is a revolutionary diagnostic tool that assesses an individual's risk of developing breast cancer in their lifetime. This innovative test analyzes specific genetic markers associated with the disease, providing valuable insights into an individual's predisposition to breast cancer.

The risk score for CanAssist Breast is a crucial component of this innovative test. It helps determine an individual's likelihood of developing breast cancer in their lifetime. This score is calculated based on various factors, including genetic markers and personal health history.

The CanAssist test for breast cancer recurrence is a groundbreaking diagnostic tool that helps in predicting the risk of cancer coming back after initial treatment. It analyzes specific genetic markers and provides an individualized risk score to guide further treatment decisions.

Ideally, CanAssist should be performed before any signs or symptoms of breast cancer appear. Early detection is key in successfully treating breast cancer, so it's important to identify potential risks as early as possible.

One common test used to confirm the presence of breast cancer is a biopsy. During this procedure, a small sample of tissue is taken from the suspicious area and sent to a laboratory for analysis. The tissue sample can be obtained through various methods such as fine needle aspiration, core needle biopsy, or surgical biopsy.

How to Book Canassist - Breast (L) at Home Near Me?

You can easily book with Max Lab by Max Hospitals. Just follow these simple steps:

Search for Canassist - Breast (L) near me on Google and click the Max Lab result, or download the Max Lab App from Google Play Store or App Store.
Select Canassist - Breast (L) from the "Book a test" button or search bar.
Add any other tests you want to include with Canassist - Breast (L) for home collection.
Choose a convenient date and time slot for sample collection.
A trained phlebotomist will visit your home or office at the scheduled time to collect your sample safely.
Track your order at each step and view its status.
Your sample is processed at the nearest Max Hospital or Lab, and reports are delivered within the specified time.
Compare results with previous reports using Max Lab's health tracking feature.

Queries about this test

#1 Canassist - Breast Test meaning

Ans: Canassist - Breast Test, also known as CanBREAST, is a revolutionary screening tool designed to detect breast cancer at an early stage. It utilizes advanced technology and artificial intelligence algorithms to analyze images of the breasts and identify potential abnormalities.

#2 Risk in Canassist - Breast Test

Ans: First and foremost, it's important to understand that any medical procedure carries some level of risk. The Canassist - Breast Test involves taking a small tissue sample from the breast, which can result in bleeding or infection at the site of biopsy. However, these risks are generally minimal and can typically be managed effectively by healthcare professionals.

#3 Canassist - Breast Test procedure

Ans: During the procedure, the patient will be asked to remove their clothing from the waist up and put on a gown. The technician will then position the patient in front of the Canassist machine and instruct them on how to place their breasts onto two plates attached to the device.

#4 Use of Canassist - Breast Test

Ans: The use of Canassist - Breast Test is crucial in detecting breast cancer at an early stage. This test helps in identifying the presence of specific genetic mutations that are associated with a higher risk of developing breast cancer.

#5 Canassist - Breast Test meaning in hindi

Ans: कैनासिस्ट - ब्रेस्ट टेस्ट, जिसे कैनब्रेस्ट के नाम से भी जाना जाता है, एक क्रांतिकारी स्क्रीनिंग टूल है जिसे शुरुआती चरण में स्तन कैंसर का पता लगाने के लिए डिज़ाइन किया गया है। यह स्तनों की छवियों का विश्लेषण करने और संभावित असामान्यताओं की पहचान करने के लिए उन्नत तकनीक और कृत्रिम बुद्धिमत्ता एल्गोरिदम का उपयोग करता है।

About Canassist - Breast (L) Test

Canassist breast cancer test is a predictive diagnostic tool that helps determine the risk of recurrence in early-stage, hormone receptor-positive breast cancer. Using advanced technology, the Canassist breast test analyses tumour biology through protein expression. When is the Test Prescribed? Canassist breast cancer can develop due to a combination of genetic, hormonal, and lifestyle factors. The primary causes include age and gender, with women over the age of 40 being most commonly aff

When is the Test Prescribed?

Time Required for Test Report + Next Step

At MAX Lab, the Canassist breast test procedure is streamlined to offer patients a seamless and efficient diagnostic experience.

Test Procedure

Sample Collection: The Canassist Breast test requires a formalin-fixed paraffin-embedded (FFPE) tumour tissue sample, usually obtained after a biopsy or surgery.
Lab Analysis: Forward the sample to a specialised laboratory where the expression of five crucial protein biomarkers is analysed using immunohistochemistry (IHC). The Canassist Breast lab test uses a proprietary algorithm to assign a risk category.
Test Duration: The Canassist Breast test report is generally available within 10 to 14 working days once the tissue sample is received at the lab.

Understanding the Test Report

The Canassist Breast test results provide a risk score and indicate whether the patient falls into the low- or high-risk category:

Low-risk: Likely to benefit from hormone therapy alone
High-risk: May require chemotherapy in addition to hormone therapy

The detailed Canassist breast test report includes:

Risk score
Biomarker details
Clinical interpretation
Treatment recommendations for oncologists

Next Steps After the Report

Once the Canassist breast test report is ready, MAX Lab coordinates a consultation with the oncology team. During this consultation, the oncologist:

Explains the risk score and its implications
Recommends treatment based on risk category
Discusses side effects, next steps, and long-term management

This multidisciplinary approach ensures every patient receives personalised, evidence-based care.

Quick Summary: The Canassist - Breast (L) is a diagnostic test, for both men and women across all age groups, with reports available within 15 Days — currently offered at ₹75000 . Home Sample Collection is available

View / Download Sample Report

Certified

Phlebotomist

🏥

Division of

Max Healthcare

🧪

Safe Sample

Collection

📊

Accurate &

Quality Reports

⏱️

Same Day

Report*

Trusted by Professionals

Overview of the Test
When is the Test Prescribed?
Time Required for Test Report + Next Step
Test Procedure
Understanding the Test Report
Next Steps After the Report
How to Book Canassist - Breast (L) at Home Near Me?
Frequently Asked Questions (FAQs) about Canassist - Breast (L)

Overview of the Test

The test works by analysing five specific protein biomarkers related to cancer progression and metastasis. Based on the results, the Canassist breast test report categorises patients into:

Low-risk: this indicates chemotherapy may not be necessary
High-risk: suggests chemotherapy might be beneficial

This classification plays a vital role in treatment planning post-surgery, helping oncologists tailor treatment to individual patients.

When is the Test Prescribed?

Time Required for Test Report + Next Step

At MAX Lab, the Canassist breast test procedure is streamlined to offer patients a seamless and efficient diagnostic experience.

Test Procedure

Sample Collection: The Canassist Breast test requires a formalin-fixed paraffin-embedded (FFPE) tumour tissue sample, usually obtained after a biopsy or surgery.
Lab Analysis: Forward the sample to a specialised laboratory where the expression of five crucial protein biomarkers is analysed using immunohistochemistry (IHC). The Canassist Breast lab test uses a proprietary algorithm to assign a risk category.
Test Duration: The Canassist Breast test report is generally available within 10 to 14 working days once the tissue sample is received at the lab.

Understanding the Test Report

The Canassist Breast test results provide a risk score and indicate whether the patient falls into the low- or high-risk category:

Low-risk: Likely to benefit from hormone therapy alone
High-risk: May require chemotherapy in addition to hormone therapy

The detailed Canassist breast test report includes:

Risk score
Biomarker details
Clinical interpretation
Treatment recommendations for oncologists

Next Steps After the Report

Once the Canassist breast test report is ready, MAX Lab coordinates a consultation with the oncology team. During this consultation, the oncologist:

Explains the risk score and its implications
Recommends treatment based on risk category
Discusses side effects, next steps, and long-term management

This multidisciplinary approach ensures every patient receives personalised, evidence-based care.

Frequently Asked Questions (FAQs) about Canassist - Breast (L)

How to Book Canassist - Breast (L) at Home Near Me?

You can easily book with Max Lab by Max Hospitals. Just follow these simple steps:

Search for Canassist - Breast (L) near me on Google and click the Max Lab result, or download the Max Lab App from Google Play Store or App Store.
Select Canassist - Breast (L) from the "Book a test" button or search bar.
Add any other tests you want to include with Canassist - Breast (L) for home collection.
Choose a convenient date and time slot for sample collection.
A trained phlebotomist will visit your home or office at the scheduled time to collect your sample safely.
Track your order at each step and view its status.
Your sample is processed at the nearest Max Hospital or Lab, and reports are delivered within the specified time.
Compare results with previous reports using Max Lab's health tracking feature.

Queries about this test

#1 Canassist - Breast Test meaning

Ans: Canassist - Breast Test, also known as CanBREAST, is a revolutionary screening tool designed to detect breast cancer at an early stage. It utilizes advanced technology and artificial intelligence algorithms to analyze images of the breasts and identify potential abnormalities.

#2 Risk in Canassist - Breast Test

Ans: First and foremost, it's important to understand that any medical procedure carries some level of risk. The Canassist - Breast Test involves taking a small tissue sample from the breast, which can result in bleeding or infection at the site of biopsy. However, these risks are generally minimal and can typically be managed effectively by healthcare professionals.

#3 Canassist - Breast Test procedure

Ans: During the procedure, the patient will be asked to remove their clothing from the waist up and put on a gown. The technician will then position the patient in front of the Canassist machine and instruct them on how to place their breasts onto two plates attached to the device.

#4 Use of Canassist - Breast Test

Ans: The use of Canassist - Breast Test is crucial in detecting breast cancer at an early stage. This test helps in identifying the presence of specific genetic mutations that are associated with a higher risk of developing breast cancer.

#5 Canassist - Breast Test meaning in hindi

Ans: कैनासिस्ट - ब्रेस्ट टेस्ट, जिसे कैनब्रेस्ट के नाम से भी जाना जाता है, एक क्रांतिकारी स्क्रीनिंग टूल है जिसे शुरुआती चरण में स्तन कैंसर का पता लगाने के लिए डिज़ाइन किया गया है। यह स्तनों की छवियों का विश्लेषण करने और संभावित असामान्यताओं की पहचान करने के लिए उन्नत तकनीक और कृत्रिम बुद्धिमत्ता एल्गोरिदम का उपयोग करता है।

About Canassist - Breast (L) Test

Canassist breast cancer test is a predictive diagnostic tool that helps determine the risk of recurrence in early-stage, hormone receptor-positive breast cancer. Using advanced technology, the Canassist breast test analyses tumour biology through protein expression. When is the Test Prescribed? Canassist breast cancer can develop due to a combination of genetic, hormonal, and lifestyle factors. The primary causes include age and gender, with women over the age of 40 being most commonly aff

When is the Test Prescribed?

Time Required for Test Report + Next Step

At MAX Lab, the Canassist breast test procedure is streamlined to offer patients a seamless and efficient diagnostic experience.

Test Procedure

Sample Collection: The Canassist Breast test requires a formalin-fixed paraffin-embedded (FFPE) tumour tissue sample, usually obtained after a biopsy or surgery.
Lab Analysis: Forward the sample to a specialised laboratory where the expression of five crucial protein biomarkers is analysed using immunohistochemistry (IHC). The Canassist Breast lab test uses a proprietary algorithm to assign a risk category.
Test Duration: The Canassist Breast test report is generally available within 10 to 14 working days once the tissue sample is received at the lab.

Understanding the Test Report

The Canassist Breast test results provide a risk score and indicate whether the patient falls into the low- or high-risk category:

Low-risk: Likely to benefit from hormone therapy alone
High-risk: May require chemotherapy in addition to hormone therapy

The detailed Canassist breast test report includes:

Risk score
Biomarker details
Clinical interpretation
Treatment recommendations for oncologists

Next Steps After the Report

Once the Canassist breast test report is ready, MAX Lab coordinates a consultation with the oncology team. During this consultation, the oncologist:

Explains the risk score and its implications
Recommends treatment based on risk category
Discusses side effects, next steps, and long-term management

This multidisciplinary approach ensures every patient receives personalised, evidence-based care.

Customer Reviews

5 out of 5

5 star

100%

4 star

3 star

Review this test

Share your thoughts with others

Dipanshu

Max Lab has become my go-to for health tests. The staff is professional, the process is smooth, and I always feel confident about the accuracy of their reports. Highly trustworthy!

Dipanshu

Max Lab has become my go-to for health tests. The staff is professional, the process is smooth, and I always feel confident about the accuracy of their reports. Highly trustworthy!

Simar

Opted for the Max Care Health Check 3 package—perfectly covered what I needed. Loved that they offer different packages based on age and lifestyle!

Diya

I received my reports via SMS and email within 24 hours. Logging in with OTP was seamless, and the report format was easy to understand. Very efficient!

Vansh

The technician arrived right on time. The entire process felt clean and safe. Ideal for anyone who prefers testing from home!

Swayam

Booked a full-body checkup through the Max Lab website in less than 2 minutes. Loved how I could select my city and get location-specific pricing. Super convenient!